Biotia Provides Microbial Surveillance for Hospitals
On average, one in 25 people who check in to a hospital get an infection— and one in nine die of that infection. 70% of these cases are caused by antimicrobial resistance pathogens. Studies show that active pathogen surveillance and tailored interventions significantly reduce hospital-acquired infections. However, current approaches to identify pathogens, including culturing and PCR are slow, labor intensive, or limited.
Working across hospitals, we leverage next-generation DNA sequencing, and artificial intelligence, for affordable active surveillance of high risk units and high risk patients to identify and stop pathogens before patients get sick.